Identification of ribosomal protein S25 (RPS25)–MDM2–p53 regulatory feedback loop
暂无分享,去创建一个
Hui Wang | Ruiwen Zhang | H. Wang | Wei Wang | Xu Zhang | Ming-Hai Wang | W. Wang | R. Zhang | Wenrong Xu | W Wang | X Zhang | H Wang | M-H Wang | W Xu | R Zhang | W. Xu | X. Zhang | M. Wang | R. Zhang | Ming-Hai Wang
[1] Yu Pan,et al. MDM2 Promotes Ubiquitination and Degradation of MDMX , 2003, Molecular and Cellular Biology.
[2] S. Ramón y. Cajal,et al. Expression of the ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors. , 2011, Human pathology.
[3] J. Leal,et al. Loss-of-function genetic screening identifies a cluster of ribosomal proteins regulating p53 function. , 2008, Carcinogenesis.
[4] K. Vousden,et al. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway , 2008, Oncogene.
[5] Petra de Graaf,et al. Critical Role for a Central Part of Mdm2 in the Ubiquitylation of p53 , 2003, Molecular and Cellular Biology.
[6] Lawrence A. Donehower,et al. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.
[7] M. Dai,et al. Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition , 2004, Molecular and Cellular Biology.
[8] M. Jackson,et al. MdmX Protects p53 from Mdm2-Mediated Degradation , 2000, Molecular and Cellular Biology.
[9] M. Dai,et al. 5-Fluorouracil Activation of p53 Involves an MDM2-Ribosomal Protein Interaction* , 2007, Journal of Biological Chemistry.
[10] K. Bhat,et al. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. , 2010, Cancer cell.
[11] B. Ebert,et al. Ribosomopathies: human disorders of ribosome dysfunction. , 2010, Blood.
[12] Xin Lu,et al. Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.
[13] T. Allio,et al. Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway , 2003, Molecular and Cellular Biology.
[14] M. Kubbutat,et al. Regulation of HDM2 activity by the ribosomal protein L11. , 2003, Cancer cell.
[15] M. Center,et al. Regulation of ribosomal protein S25 in HL60 cells isolated for resistance to adriamycin , 1992, FEBS letters.
[16] Jiandong Chen,et al. MDMX regulation of p53 response to ribosomal stress , 2006, The EMBO journal.
[17] P. Pandolfi,et al. Does the ribosome translate cancer? , 2003, Nature Reviews Cancer.
[18] Yanping Zhang,et al. Signaling to p53: ribosomal proteins find their way. , 2009, Cancer cell.
[19] W. Wang,et al. Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function , 2007, Oncogene.
[20] N. Nakashima,et al. Eukaryotic ribosomal protein RPS25 interacts with the conserved loop region in a dicistroviral intergenic internal ribosome entry site , 2007, Nucleic acids research.
[21] Bert Vogelstein,et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.
[22] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[23] K. B. McIntosh,et al. How common are extraribosomal functions of ribosomal proteins? , 2009, Molecular cell.
[24] B. Wasylyk,et al. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability , 2001, Oncogene.
[25] F. Mancini,et al. Puzzling over MDM4-p53 network. , 2010, The international journal of biochemistry & cell biology.
[26] Moshe Oren,et al. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. , 2008, Molecular cell.
[27] M. Dai,et al. Regulation of the MDM2-p53 Pathway by Ribosomal Protein L11 Involves a Post-ubiquitination Mechanism* , 2006, Journal of Biological Chemistry.
[28] Michael A. Dyer,et al. MDMX: from bench to bedside , 2007, Journal of Cell Science.
[29] M. Dai,et al. Mycophenolic Acid Activation of p53 Requires Ribosomal Proteins L5 and L11* , 2008, Journal of Biological Chemistry.
[30] T. Adilakshmi,et al. Ribosomal Protein S25 mRNA Partners with MTF-1 and La to Provide a p53-mediated Mechanism for Survival or Death* , 2002, The Journal of Biological Chemistry.
[31] N. Little,et al. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms , 2001, EMBO reports.
[32] X. Jacq,et al. Ribosomal protein S7 is both a regulator and a substrate of MDM2. , 2009, Molecular cell.
[33] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[34] M. Oren,et al. Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis. , 2012, Molecular cell.
[35] M. Dai,et al. Interplay between Ribosomal Protein S27a and MDM2 Protein in p53 Activation in Response to Ribosomal Stress* , 2011, The Journal of Biological Chemistry.
[36] A. Levine,et al. The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.
[37] A. Marchetti,et al. MDM4 (MDMX) localizes at the mitochondria and facilitates the p53‐mediated intrinsic‐apoptotic pathway , 2009, The EMBO journal.
[38] J. Levine,et al. Surfing the p53 network , 2000, Nature.
[39] W. Loging,et al. Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[40] M. Takagi,et al. Regulation of p53 Translation and Induction after DNA Damage by Ribosomal Protein L26 and Nucleolin , 2005, Cell.
[41] A. Ciechanover,et al. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[42] Hui Wang,et al. RYBP stabilizes p53 by modulating MDM2 , 2009, EMBO reports.
[43] Yi Sun,et al. Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis s a target, a substrate, and a regulator , 2010, Oncogene.
[44] A. Budde,et al. p53 represses ribosomal gene transcription , 1999, Oncogene.
[45] K. Itahana,et al. Inhibition of HDM2 and Activation of p53 by Ribosomal Protein L23 , 2004, Molecular and Cellular Biology.
[46] Wei Gu,et al. p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.
[47] J. Marine,et al. Mdm2-mediated ubiquitylation: p53 and beyond , 2010, Cell Death and Differentiation.
[48] S. Thompson,et al. RPS25 is essential for translation initiation by the Dicistroviridae and hepatitis C viral IRESs. , 2009, Genes & development.
[49] Valerie Reinke,et al. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53 , 2001, Nature Genetics.
[50] Chad Deisenroth,et al. Cancer-Associated Mutations in the MDM2 Zinc Finger Domain Disrupt Ribosomal Protein Interaction and Attenuate MDM2-Induced p53 Degradation , 2006, Molecular and Cellular Biology.
[51] A. Levine,et al. The first 30 years of p53: growing ever more complex , 2009, Nature Reviews Cancer.
[52] Ruiwen Zhang,et al. Proteasome activator PA28γ regulates p53 by enhancing its MDM2-mediated degradation , 2008, The EMBO journal.
[53] M. Kilberg,et al. Nuclear retention of the induced mRNA following amino acid-dependent transcriptional regulation of mammalian ribosomal proteins L17 and S25. , 1994, The Journal of biological chemistry.
[54] K. Bhat,et al. Essential role of ribosomal protein L11 in mediating growth inhibition‐induced p53 activation , 2004, The EMBO journal.
[55] M. Dai,et al. Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5* , 2004, Journal of Biological Chemistry.
[56] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.